Management of right ventricular failure in the era of ventricular assist device therapy.

Curr Heart Fail Rep

Division of Cardiology, Medical University of South Carolina, 25 Courtenay Drive, Charleston, SC 29425-5920, USA.

Published: March 2011

AI Article Synopsis

  • The rise in advanced heart failure cases and the shortage of donor hearts have made left ventricular assist devices (LVADs) a popular choice for treating end-stage heart failure.
  • Right ventricular failure (RVF) often occurs during LVAD surgery, leading to serious health issues and higher death rates.
  • This review covers the causes of RVF, approaches to evaluate patient risk before surgery, and management strategies before, during, and after the operation.

Article Abstract

The increasing incidence of patients with advanced heart failure, limited donor availability, and continued advancements in the field of mechanical circulatory support have made implantation of left ventricular assist device therapy (LVAD) an attractive option for patients with end-stage heart failure. Perioperative right ventricular failure (RVF) occurs frequently in patients undergoing LVAD implantation and is associated with significant morbidity and mortality. This review will discuss the pathophysiology of RVF, recent efforts to risk-stratify patients preoperatively, and current preoperative, perioperative, and postoperative management strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11897-010-0043-3DOI Listing

Publication Analysis

Top Keywords

ventricular failure
8
ventricular assist
8
assist device
8
device therapy
8
heart failure
8
management ventricular
4
failure
4
failure era
4
era ventricular
4
therapy increasing
4

Similar Publications

Advanced Markers for Hemodynamic Monitoring in Cardiogenic Shock and End-Stage Heart Failure: A Mini Review.

Heart Fail Rev

January 2025

Division of Cardiovascular Medicine, University of Utah Health & School of Medicine, 30 N Mario Capecchi Drive, HELIX Building 3rd Floor, Salt Lake City, UT, 84112, USA.

Right heart catheterization (RHC) provides critical hemodynamic insights by measuring atrial, ventricular, and pulmonary artery pressures, as well as cardiac output (CO). Although the use of RHC has decreased, its application has been linked to improved outcomes. Advanced hemodynamic markers such as cardiac power output (CPO), aortic pulsatility index (API), pulmonary artery pulsatility index (PAPi), right atrial pressure to pulmonary capillary wedge pressure ratio (RAP/PCWP) and right ventricular stroke work index (RVSWI) have been introduced to enhance risk stratification in cardiogenic shock (CS) and end-stage heart failure (HF) patients.

View Article and Find Full Text PDF

Heart remodelling affects ECG in rat DOCA/salt model.

Physiol Res

December 2024

Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Myocardial remodelling involves structural and functional changes in the heart, potentially leading to heart failure. The deoxycorticosterone acetate (DOCA)/salt model is a widely used experimental approach to study hypertension-induced cardiac remodelling. It allows to investigate the mechanisms underlying myocardial fibrosis and hypertrophy, which are key contributors to impaired cardiac function.

View Article and Find Full Text PDF

Although the heart atria have a lesser functional importance than the ventricles, atria play an important role in the pathophysiology of heart failure and supraventricular arrhythmias, particularly atrial fibrillation. In addition, knowledge of atrial morphology recently became more relevant as cardiac electrophysiology and interventional procedures in the atria gained an increasingly significant role in the clinical management of patients with heart disease. The atrial chambers are thin-walled, and several vessels enter at the level of the atria.

View Article and Find Full Text PDF

Congenital heart disease (CHD) is the most common congenital anomaly in newborns. Advances in catheter and surgical techniques led to the majority of these patients surviving into adulthood, leading to evolving challenges due to the emergence of long-term complications such as arrhythmias. Interventional electrophysiology (EP) has had remarkable advances over the last few decades, and various techniques and devices have been explored to treat adult patients with CHD.

View Article and Find Full Text PDF

Unmasking High-Output Heart Failure: Beyond Conventional Paradigms.

Cardiol Rev

January 2025

From the Department of Internal Medicine, Division of Cardiology, Wayne State University, Detroit, MI.

Heart failure (HF) poses a significant medical challenge, affecting millions of adults in the United States. High-output heart failure (HOHF) is a distinct subtype characterized by elevated cardiac output exceeding 8 L/min or a cardiac index >4 L/min/m². Patients with HOHF often present similarly to those with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!